Financials Cementos Bio Bio S.A.

Equities

CEMENTOS

CLP2234F1031

Construction Materials

End-of-day quote Santiago S.E. 03:30:00 07/05/2024 am IST 5-day change 1st Jan Change
702 CLP 0.00% Intraday chart for Cementos Bio Bio S.A. 0.00% +6.36%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,40,309 2,11,377 1,95,946 1,84,978 1,71,215 1,74,386
Enterprise Value (EV) 1 3,25,453 2,97,931 2,62,558 2,66,267 2,83,357 2,83,749
P/E ratio 12.2 x 16.1 x 14.2 x 6.88 x 16.2 x 7.65 x
Yield 4.07% 2% 5.66% 6.86% 1.85% 5.45%
Capitalization / Revenue 0.92 x 0.8 x 0.81 x 0.64 x 0.51 x 0.5 x
EV / Revenue 1.24 x 1.13 x 1.08 x 0.92 x 0.85 x 0.81 x
EV / EBITDA 9.88 x 10.9 x 7.54 x 8.8 x 11.7 x 5.9 x
EV / FCF 40.3 x 35.8 x 9.68 x -28.8 x 32.4 x 18.3 x
FCF Yield 2.48% 2.79% 10.3% -3.48% 3.08% 5.47%
Price to Book 1.04 x 0.89 x 0.81 x 0.72 x 0.71 x 0.68 x
Nbr of stocks (in thousands) 2,64,221 2,64,221 2,64,221 2,64,221 2,64,221 2,64,221
Reference price 2 909.5 800.0 741.6 700.1 648.0 660.0
Announcement Date 28/03/19 26/03/20 31/03/21 31/03/22 31/03/23 28/03/24
1CLP in Million2CLP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,62,569 2,63,182 2,42,586 2,89,468 3,34,004 3,48,984
EBITDA 1 32,943 27,229 34,832 30,270 24,159 48,082
EBIT 1 21,861 16,553 23,062 17,086 11,415 34,887
Operating Margin 8.33% 6.29% 9.51% 5.9% 3.42% 10%
Earnings before Tax (EBT) 1 21,885 15,044 16,263 33,911 5,635 26,622
Net income 1 19,773 13,104 13,763 26,879 10,560 22,797
Net margin 7.53% 4.98% 5.67% 9.29% 3.16% 6.53%
EPS 2 74.84 49.59 52.09 101.7 39.97 86.28
Free Cash Flow 1 8,067 8,320 27,121 -9,254 8,739 15,534
FCF margin 3.07% 3.16% 11.18% -3.2% 2.62% 4.45%
FCF Conversion (EBITDA) 24.49% 30.56% 77.86% - 36.17% 32.31%
FCF Conversion (Net income) 40.8% 63.49% 197.06% - 82.75% 68.14%
Dividend per Share 2 37.00 16.00 42.00 48.00 12.00 36.00
Announcement Date 28/03/19 26/03/20 31/03/21 31/03/22 31/03/23 28/03/24
1CLP in Million2CLP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 85,144 86,554 66,612 81,288 1,12,142 1,09,363
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.585 x 3.179 x 1.912 x 2.685 x 4.642 x 2.275 x
Free Cash Flow 1 8,067 8,320 27,121 -9,254 8,739 15,534
ROE (net income / shareholders' equity) 8.64% 5.51% 5.79% 10.8% 4.23% 9.16%
ROA (Net income/ Total Assets) 3.07% 2.33% 3.26% 2.28% 1.48% 4.51%
Assets 1 6,43,443 5,62,376 4,22,298 11,76,836 7,13,897 5,05,558
Book Value Per Share 2 874.0 898.0 918.0 971.0 912.0 968.0
Cash Flow per Share 2 135.0 80.80 153.0 156.0 40.40 51.50
Capex 1 16,243 12,447 9,339 21,976 13,808 18,144
Capex / Sales 6.19% 4.73% 3.85% 7.59% 4.13% 5.2%
Announcement Date 28/03/19 26/03/20 31/03/21 31/03/22 31/03/23 28/03/24
1CLP in Million2CLP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. CEMENTOS Stock
  4. Financials Cementos Bio Bio S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW